References
- Tolman KG, Sanders SW, Buchi KN. Gastric pH levels after 15 mg and 30 mg of lansoprazole and 20 mg omeprazole. Gastroenterology. 1994;106:
A197 . - Boulliat J, Polard E, Colin F, Bentué-Ferrer D, Allain H. Encéphalopathie myoclonique: rôle des inhibiteurs de la pompe à protons [Myoclonic encephalopathy associated with proton pump inhibitors]. Rev Neurol (Paris). 2004;160(3):350–351. DOI: 10.1016/S0035-3787(04)70912-1
- Patani OD, Zaidi R, Koss K, Davison C. Lansoprazole: Recurrent hypomagnesaemia: an uncommon complication of a common drug. React. Wkly. 2012;1419:
32 . DOI: 10.2165/00128415-201214190-00118 - Kojovic M, Cordivari C, Bhatia K. Myoclonic disorders: A practical approach for diagnosis and treatment. Ther Adv Neurol Disord. 2011;4:47–62. DOI: 10.1177/1756285610395653
- Caviness JN. Treatment of Myoclonus. Neurotherapeutics. 2014;11:188–200. DOI: 10.1007/s13311-013-0216-3
DOI: https://doi.org/10.5334/tohm.1236 | Journal eISSN: 2160-8288
Language: English
Page range: 47 - 47
Submitted on: May 14, 2026
Accepted on: Jul 30, 2026
Published on: Aug 14, 2026
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Keywords:
© 2026 R. N. Komal Kumar, Vijay K. Sharma, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.